University Marks Official Opening of New Biomedical Research Facility
News Jul 15, 2013
Two research centres, one focusing on cardiovascular and metabolic diseases and the other on cancer are located in the building. The University has an international reputation in both of these areas, and by bringing together both academics and health professionals, it aims to quickly translate research into tangible benefits for patients.
Professor John Greenman, Head of the School of Biological, Biomedical and Environmental Sciences, said: “It has been a pleasure to watch this fantastic facility develop from an idea through to reality. The new facilities provide the University of Hull with a significant boost to our research capabilities to tackle cancer and cardiovascular disease. The building provides a physical home for our current and future collaborative work.”
The building has been made possible by a generous £1.5 million donation from leading East Yorkshire businessman, Dr Assem Allam. It will be officially opened by Sir Paul Nurse, President of the Royal Society, Nobel Prize winner and an honorary graduate of the University. Funding for some of the vital high-tech equipment and key research being undertaken at the centre has also been generously provided by local medical charity, the Daisy Appeal.
Dr Allam said: “I have long been a supporter of medical research because I want my donations to make the biggest impact on peoples’ lives that they possibly can.
“I believe wholeheartedly that medical research, and particularly research into society’s most prevalent killers such as cancer and heart disease, is the best way to ensure this happens. After all, these conditions touch everyone, old or young, rich or poor and all nationalities.
“It was an honour to have provided the money to create such a wonderful facility and it is an honour for me that it bears my name. I am extremely proud to see it finally completed.
“The Allam Building will not only help the University of Hull remain at the forefront of cutting edge medical research, it will lead to more lives being saved and money can be put to no better purpose than that.”
University of Hull Vice-Chancellor, Professor Calie Pistorius, said: “The University of Hull is very proud of this state-of-the-art facility, which not only brings together expertise from across the region to benefit patients, but helps us strengthen our position as a centre of research excellence.
“This is one of many initiatives which the University is implementing to further enhance the quality of our student experience and our international reputation.”
Insulin Goes Viral: Diabetes and Cancer-causing Mechanisms ExploredNews
Every cell in your body responds to the hormone insulin, and if that process starts to fail, you get diabetes. In an unexpected finding, scientists have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer.READ MORE
Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”News
Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.
Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.
Understanding the Process of Cell DivisionNews
Using multiple techniques such as structural modelling, X-ray scattering, X-ray crystallography and electron microscopy, scientists have found that the Spc110 protein provides a greater function in mitosis originally believed. This information could help understand the process in human cells and the abnormalities that occur in cancer.READ MORE
Comments | 0 ADD COMMENT
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018